Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

WL Wang, A Conley, D Reynoso, L Nolden… - Cancer chemotherapy …, 2011 - Springer
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …
被引用次数：97 相关文章

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

WL Wang, A Conley, D Reynoso… - Cancer …, 2011 - scholarship.miami.edu
Abstract Protein Kinase Inhibitors-pharmacokinetics Pyrroles-pharmacokinetics Humans
Drug Resistance, Neoplasm Antineoplastic Agents-therapeutic use Piperazines-therapeutic …

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.

WL Wang, A Conley, D Reynoso… - Cancer …, 2011 - search.ebscohost.com
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

WL Wang, A Conley, D Reynoso… - Cancer …, 2011 - pubmed.ncbi.nlm.nih.gov
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …

[引用][C] Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

WL WANG, A CONLEY, D REYNOSO… - Cancer …, 2011 - pascal-francis.inist.fr
Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

W Wang, A Conley, D Reynoso… - Cancer …, 2011 - search.proquest.com
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

WL Wang, A Conley, D Reynoso, L Nolden… - Cancer Chemotherapy …, 2011 - infona.pl
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

WL Wang, A Conley, D Reynoso… - Cancer …, 2011 - mdanderson.elsevierpure.com
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …
[PDF] academia.edu

[PDF][PDF] Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

WL Wang, A Conley, D Reynoso, L Nolden… - Cancer Chemother …, 2011 - academia.edu
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.

WL Wang, A Conley, D Reynoso, L Nolden… - Cancer …, 2010 - europepmc.org
Gastrointestinal stromal tumor (GIST), the most common mesenchymal neoplasm of the GI
tract and one of the most common sarcomas, is dependent on the expression of the mutated …